Article thumbnail

Involvement of Aberrant Glycosylation in Thyroid Cancer

By Eiji Miyoshi, Yasuhiro Ito and Yoko Miyoshi

Abstract

Glycosylation is one of the most common posttranslational modification reactions and nearly half of all known proteins in eukaryotes are glycosylated. In fact, changes in oligosaccharides structures are associated with many physiological and pathological events, including cell growth, migration and differentiation, and tumor invasion. Therefore, functional glycomics, which is a comprehensive study of the structures and functions of glycans, is attracting the increasing attention of scientists in various fields of life science. In cases of thyroid cancer, the biological characters and prognosis are completely different in each type of histopathology, and their oligosaccharide structures as well as the expression of glycosyltransferases are also different. In this review, we summarized our previous papers on oligosaccharides and thyroid cancers and discussed a possible function of oligosaccharides in the carcinogenesis in thyroid cancer

Topics: Review Article
Publisher: Hindawi Publishing Corporation
OAI identifier: oai:pubmedcentral.nih.gov:2906155
Provided by: PubMed Central

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.

Suggested articles

Citations

  1. (1993). A collaborative study for the evaluation of lectin-reactive α- fetoproteins in early detection of hepatocellular carcinoma,”
  2. (2006). A secreted type of β1, 6 N-acetylglucosaminyltransferase V (GnT-V), a novel angiogenesis inducer, is regulated by γ-secretase,”
  3. (2002). A secreted type of β1,6-N-acetylglucosaminyltransferase V (GnT-V) induces tumor angiogenesis without mediation of glycosylation. A novel function of GnT-V distinct from the original glycosyltransferase activity,”
  4. (2004). Addition of β1-6 GlcNAc branching to the oligosaccharide attached to
  5. (1993). Biological roles of oligosaccharides: all of the theories are correct,”
  6. (2006). Cern´ a, I. Kholov´ a, and E. Brabencov´ a, “Neoplastic transformation of the thyroid gland is accompanied by changes in cellular sialylation,”
  7. (2001). Chemical and biological strategies for engineering cell surface glycosylation,”
  8. (2006). Co-expression of matriptase and N-acetylglucosaminyltransferase V in thyroid cancer tissues; its possiblerolein prolonged stabilityin vivo by aberrant glycosylation,”
  9. (2007). Complex Nglycan number and degree of branching cooperate to regulate cell proliferation and differentiation,”
  10. (2008). Cytoplasmic and serum galectin-3 in diagnosis of thyroid malignancies,”
  11. (2006). Decoding sugar functions by identifying target glycoproteins,”
  12. (1983). Distinct molecular species of human α-fetoprotein due to differential affinities to lectins,”
  13. (2005). Dysregulation of TGF-β1 receptor activation leads to abnormal lung development and emphysema-like phenotype in core fucose-deficient mice,”
  14. (2003). Expression of α1, 6-fucosyltransferase (FUT8) in papillary carcinoma of the thyroid: its linkage to biological aggressiveness and anaplastic transformation,”
  15. (2008). Galectin3-expression analysis in the surgical selection of follicular thyroid nodules with indeterminate fine-needle aspiration cytology: a prospective multicentre study,”
  16. (1995). Glycobiology: “Towards understanding the function of sugars”,”
  17. (1999). Glycoprotein glycosylation and cancer progression,”
  18. (2003). Glypican-3: a novel serum and histochemical marker for hepatocellular carcinoma,”
  19. (2005). Glypican3 promotes the growth of hepatocellular carcinoma by stimulatingcanonicalWntsignaling,”CancerResearch,vol.65,
  20. (2001). Glypicans: proteoglycans with a surprise,”
  21. (1999). Implication of N-acetylglucosaminyltransferases III and V in cancer: gene regulation and signaling mechanism,”
  22. K.Moriwaki,K.Noda,Y.Furukawaetal.,“DeficiencyofGMD leads to escape from NK cell-mediated tumor surveillance through modulation of TRAIL signaling,”
  23. (1981). Microheterogeneity of α-fetoprotein in patient serum as demonstrated by lectin affino-electrophoresis,”
  24. (2008). Okuyama et al., “Immunohistochemical study of glypican 3 in thyroid cancer,”
  25. (2002). Prometastatic effect of N-acetylglucosaminyltransferase V is due to modification and stabilization of active matriptase by adding β1-6 GlcNAc branching,”
  26. (1996). Purification and cDNA cloning of porcine brain GDP-L-Fuc:N-acetyl-β-Dglucosaminide α1→6 fucosyltransferase,”
  27. (1999). Purification and characterization of a complex containing matriptase and a Kunitz-type serine protease inhibitor from human milk,”
  28. (2008). Recapitulation of IVIG antiinflammatory activity with a recombinant
  29. (2004). s, “Hormonal control of protein glycosylation: role of steroids and related lipophilic ligands,”
  30. (2008). Sialic acids in human health and disease,” Trends in
  31. The Thyroid and Its Diseases, Thyroid Disease Manager.
  32. (1991). The usefulness of simultaneous determinations of glucosaminylation and fucosylation indices of alpha-fetoprotein in the differential diagnosis of neoplastic diseases of the liver,”